Introduction. Pheochromocytoma of the urinary bladder is a rare tumor and presents less than 0.06% of all urinary bladder tumors. Case report. We presented a 49-year-old female patient with a history of daily paroxysmal hypertension accompanied with flushing of the face and upper chest, palpitations and excessive sweating prior to micturition. Ultrasonography reported a 3 cm bladder wall tumor. The 131 I-metaiodobenzylguanidine ( 131 I-MIBG) scan showed a pathological isotope accumulation in the projection of the bladder. The patient underwent a partial cystectomy. One year following the operation the patient was normotensive and without recurrence. Conclusion. The most efficient treatment option for bladder pheochromocytoma is surgical resection. The most important fact in the diagnostics is suspicion on this rare condition.
Introduction
Pheochromocytoma of the urinary bladder is a rare tumor which presents less than 0.06% of all urinary bladder tumors and less than 1% of all pheochromocytomas 1, 2 . They are tumors of the chromaffin tissue of the sympathetic nervous system of the urinary bladder wall 3 . They are most frequently derived from the adrenal medulla and in approximately 10% of cases are extraadrenal 4 . In the genitourinary tract the most frequent localization is the bladder (79.2%), urethra (12.7%), renal pelvis (4.9%) and the ureter (3.2%) 2 . Aside from the localization features the diagnosis and treatment of these tumors is not much different than pheochromocytomas of other localizations.
Case report
We presented a 49-year-old female patient with a history of daily paroxysmal hypertension (from 220/130 mmHg), accompanied with flushing of the face and upper chest, palpitations and excessive sweating. The paroxysmal hypertension was preceded by morning urination. Ten minutes following the attack there was a spontaneous decrease of the blood pressure. Similar lower intensity episodes which the patient subjectively better tolerated were reported occasionally during the day after voiding. The concentration of vanillylmandelic acid (VMA) in the 24 hour urine was in two occasions in normal range. Also, normal levels of epinephrine and norepinephrine were recorded.
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Discussion
The first case of pheochromocytoma of the bladder was published by Zimmerman et al. 5 in 1953. and from that time about 200 cases have been published. Pheochromocytoma of the bladder can be diagnosed in children and the elderly, at the age of 10 to 80 years 6, 7 . It is more common in the female population [8] [9] [10] . The localization of these tumors differs in various studies. By some authors they are solitary tumors that most frequently arise on the dome or trigone of the bladder, while by other authors they are more often on the lateral bladder walls 9, 11 . Approximately 10% of urinary bladder pheochromocytomas are malignant 2 . Some authors consider invasion into surrounding organs and tissues or lymph node involvement as a criteria for malignancy 12, 13 . The presence of necrosis, angiolymphatic invasion, increase of mitosis and DNA ploidia indicate the malignant potential of the pheochromocytoma 1, 5, [14] [15] [16] [17] [18] [19] . The current literature reported clinical signs range from the micturition attacks of headaches, palpitations, visual disturbances, tachycardia, sustained or paroxysmal hypertension, hematuria, dysuria, suprapubic pain or sweating after voiding 20, 21 . In around 17% of cases tumors are hormone inactive with practically no symptoms or can be presented only by pain or hematuria 13, 19, 20 . Only 40% of cases are preoperatively diagnosed, and the majority got adequate diagnosis after bladder surgery 21 . The suspicion on bladder pheochromocytoma with the presence of the characteristic symptoms should be investigated using imaging techniques (ultrasonography, CT) measurement of hormonal metabolites, and visualization via cystoscopy [21] [22] [23] . MIBG scan is highly recommended in determining the localization and diagnosis of pheochromocytoma. Its specificity is very high (nearly 100%) 24 . Biochemical measurements of urine/plasma catecholamine's and their metabolites are mandatory, such as measurement of norepinephrine 3 hours prior and after voiding 15, 21 . The most efficient treatment option for pheochromocytomas is surgical resection. The preoperatively confirmed diagnosis and adequate preparation facilitate the safety of surgical treatment 25 . Partial cystectomy is the first choice option 8, 9, 21, 24 . There are studies where tumors were treated by transurethral resection with or without hypertension attacks and recurrence, especially tumors that were not preoperatively diagnosed as pheochromocytomas 26, 27 . Nowadays, these tumors are treated by laparascopy or by robot assisted partial cystectomy with pelvic lymph node resection in the centers of excellences [28] [29] [30] . In the follow-up for benign tumors it is recommended to do the biochemical measurements of urine/plasma catecholamine's and their metabolites every 3-6 months and 131 I-MIBG and CT scan annually 15 . Patients with malignant tumors should have a monthly check of catheholamine levels and imaging studies twice a year 31 . Long term follow-ups are necessary because there are published cases with local recurrence and development of metastasis decades following surgical treatment 32 .
Conclusion
Paraganglioma of the urinary bladder is a very rare tumor. When suspected the diagnosis can be reliably confirmed or excluded almost in all of the cases. Surgical resection is the standard treatment modality and requires the same preparation as in pheochromocytomas of different localizations. Almost all of the patients with benign tumors can be cured by surgery. The surgical mortality for all of the pheochromocytomas is around 2-3% with an experienced anesthesiologist and the surgeon. The histological confirmation of the tumor must be completed with immunohistochemical examination. Because of frequent recurrence, especially in malignant pheochromocytomas there must be a long term follow-up of these patients. The optimal treatment of these patients must be reserved for highly specialized medical centers.
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